Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
التنسيق:	Journal article
منشور في:	2009

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
حسب: Griffiths, G, وآخرون
منشور في: (2009)

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
حسب: Macbeth Fergus R, وآخرون
منشور في: (2009-10-01)

Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
حسب: Dong Qian, وآخرون
منشور في: (2015-01-01)

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
حسب: Anders Kjellberg, وآخرون
منشور في: (2023-01-01)

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis
حسب: Ken Haruma, وآخرون
منشور في: (2023-05-01)

Issues in data monitoring and interim analysis of trials.
حسب: Grant, A, وآخرون
منشور في: (2005)

CANparent trial evaluation: second interim report
حسب: Cullen, M, وآخرون
منشور في: (2014)

CANparent trial evaluation: First interim report
حسب: Cullen, M, وآخرون
منشور في: (2013)

Guidance on interim analysis methods in clinical trials
حسب: Jody D. Ciolino, وآخرون
منشور في: (2023-01-01)

Issues in data monitoring and interim analysis of trials
حسب: A Grant, وآخرون
منشور في: (2005-03-01)

Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
حسب: Masahide Oki, وآخرون
منشور في: (2024-12-01)

Impact of theta burst stimulation on face processing in autism: Interim results from a randomised controlled trial
حسب: Briella Rodriguez, وآخرون
منشور في: (2025-01-01)

Efficacy of Biosilicate Glass-Ceramic and Gluma in the Treatment of Cervical Dentin Hypersensitivity: An Interim Results of Randomised Control Trial
حسب: Maria Luiza Lima Santana, وآخرون
منشور في: (2022-04-01)

Decision on performing interim analysis for comparative clinical trials
حسب: Kyongsun Pak, وآخرون
منشور في: (2017-09-01)

Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: A survey from the Italian National Monitoring Centre for Clinical Trials
حسب: De Rosa Marisa, وآخرون
منشور في: (2008-07-01)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
حسب: Voysey, M, وآخرون
منشور في: (2020)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
حسب: Crosby, T, وآخرون
منشور في: (2017)

Monitoring clinical trials. Interim data should not be publicly available.
حسب: Richards, S
منشور في: (2001)

Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial
حسب: Shaji Sebastian, وآخرون
منشور في: (2024-07-01)

Using an integrated motor imagery and physical training intervention after knee injury: an interim analysis of the MOTIFS randomised controlled trial
حسب: Eva Ageberg, وآخرون
منشور في: (2024-10-01)

Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
حسب: María Jesús López Fernández, وآخرون
منشور في: (2024-07-01)

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
حسب: Samuel Ponce-de-León, وآخرون
منشور في: (2023-05-01)

Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
حسب: Giuseppe Fiorentino, وآخرون
منشور في: (2022-09-01)

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
حسب: Keiji Hirai, وآخرون
منشور في: (2017-06-01)

Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.
حسب: Jewell, D, وآخرون
منشور في: (1972)

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES
حسب: M. V. Shestakova, وآخرون
منشور في: (2016-05-01)

The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues
حسب: Editorial team Diabetes Mellitus
منشور في: (2016-05-01)

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers
حسب: Kathleen A. Welsh‐Bohmer, وآخرون
منشور في: (2023-10-01)

Interim analysis: A rational approach of decision making in clinical trial
حسب: Amal Kumar, وآخرون
منشور في: (2016-01-01)

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
حسب: Jensen Alexandra D, وآخرون
منشور في: (2012-04-01)

A single injection of zoledronic acid may prevent bone loss after stroke: Planned interim analysis of a randomised trial
حسب: Poole, K, وآخرون
منشور في: (2004)

Selective versus stepwise removal of deep carious lesions in permanent teeth: a randomised controlled trial from Egypt—an interim analysis
حسب: Falk Schwendicke, وآخرون
منشور في: (2019-09-01)

Children Anxiety and Pain while Performing Interim Therapeutic Restorations with Hand Instruments compared to Rotary Instruments: A Randomised Clinical Trial
حسب: Osama M Felemban, وآخرون
منشور في: (2024-01-01)

Comparison of neutral and lowered shoulder position on successful right subclavian vein catheterisation in children: An interim analysis of a randomised controlled trial
حسب: Dhirendra Pratap Singh, وآخرون
منشور في: (2018-01-01)

Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
حسب: Thuy P. Nguyen, وآخرون
منشور في: (2022-07-01)

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
حسب: Punnee Pitisuttithum, وآخرون
منشور في: (2022-03-01)

Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial
حسب: Anders Kvanta, وآخرون
منشور في: (2024-09-01)

Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme
حسب: P. Falkai, وآخرون
منشور في: (2023-03-01)

Study Protocol for a Randomised Controlled Trial on Pulmonary Metastasectomy vs. Standard of Care in Colorectal Cancer Patients With ≥ 3 Lung Metastases (PUCC-Trial)
حسب: Severin Schmid, وآخرون
منشور في: (2022-07-01)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
حسب: Ballard, C, وآخرون
منشور في: (2008)

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

مواد مشابهة

مواد مشابهة